{
    "Trade/Device Name(s)": [
        "LIAISON\u00ae HAV IgM",
        "LIAISON\u00ae Control HAV IgM"
    ],
    "Submitter Information": "DiaSorin, Inc.",
    "510(k) Number": "K160650",
    "Predicate Device Reference 510(k) Number(s)": [
        "K082050",
        "P890014"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LOL",
        "JJX"
    ],
    "Summary Letter Date": "July 27, 2016",
    "Summary Letter Received Date": "July 28, 2016",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3310",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Hepatitis A virus (HAV) serological assays",
        "Clinical Chemistry"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "immunology"
    ],
    "Analyte(s)": [
        "IgM antibodies to hepatitis A virus (IgM anti-HAV)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Serum in serum separator tubes",
        "Plasma (Sodium Citrate)",
        "Plasma (Potassium EDTA)",
        "Plasma (Lithium Heparin)",
        "Plasma (Sodium Heparin)",
        "Plasma (Citrate Dextrose (ACD))"
    ],
    "Specimen Container(s)": [
        "Serum tube",
        "Serum separator tube",
        "Sodium Citrate tube",
        "Potassium EDTA tube",
        "Lithium Heparin tube",
        "Sodium Heparin tube",
        "Citrate Dextrose (ACD) tube"
    ],
    "Instrument(s)/Platform(s)": [
        "LIAISON\u00ae Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay (CLIA)"
    ],
    "Methodologies": [
        "Antibody capture immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for LIAISON\u00ae HAV IgM chemiluminescent immunoassay and quality control for qualitative detection of IgM anti-HAV in serum and plasma",
    "Indications for Use Summary": "Intended for qualitative detection of IgM antibodies to hepatitis A virus (IgM anti-HAV) in human serum and plasma as an aid in diagnosis of acute or recent HAV infection; controls for monitoring assay performance.",
    "fda_folder": "Microbiology"
}